Auph stock rating

Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock ... Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Aurinia Pharmaceuticals Inc. (AUPH) Quant Ratings ... The Quant Rating is an objective, quantitative view of each stock relative to other stocks in the same sector. It provides an instant summary of the available data about the stock, including the company’s financial results, the stock’s trading history, and sell-side analysts’ estimates of … AUPH Price Target and Analyst Ratings (Aurinia ... Nov 06, 2019 · Their average twelve-month price target is $17.75, suggesting that the stock has a possible upside of 205.25%. The high price target for AUPH is $25.00 and the low price target for AUPH is $11.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy.".

AUPH Stock | AURINIA PHARMACEUTICALS Stock Price Today ...

Apr 03, 2020 · AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. Ratings | Benzinga Jan 01, 2010 · Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. Popular Channels Analyst Ratings AUPH Stock Rating and Data | Aurinia Pharmaceuticals ... AUPH stock rating and analysis - Aurinia Pharmaceuticals : a summary of key financial strength and profitability metrics. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial AUPH - Aurinia Pharm Ord Stock Analyst Ratings - Barchart.com

AUPH Aurinia Pharmaceuticals Inc. — Stock Price and ...

Enter a stock ticker symbol in the field below to get our experts' instant Bull/Bear rating, ranking & more. AUPH. Aurinia Pharmaceuticals Inc Stock Price  AUPH's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Stock. AUPH. Price as of: Mar 9, 2:00 PM. $15.0 +0.57 +3.95%. Industry.

Nov 14, 2019 · Is Aurinia Pharmaceuticals a good stock to buy right now? Discover AUPH stock analysis score based on Wall Street’s best performing experts

Aurinia is a late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need. Aurinia Pharmaceuticals Inc. (AUPH) Stocktalk | Seeking Alpha Read the latest StockTalks, investment ideas, and community discussion on Aurinia Pharmaceuticals Inc. (AUPH). AUPH Stock | AURINIA PHARMACEUTICALS Stock Price Today ... Apr 03, 2020 · AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices.

Mar 09, 2020 · Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurinia Pharmaceuticals (AUPH – Research Report), BioCryst (BCRX – Research Report) and Flexion Therapeutics (FLXN – Research Report).Aurinia Pharmaceuticals (AUPH) In a report issued on March 6, Douglas Miehm from RBC Capital maintained a Buy rating on Aurinia Pharmaceuticals, with a price …

Aurinia Pharmaceuticals Inc - AUPH - Stock Price Today - Zacks

Aurinia Pharmaceuticals Inc. (AUPH) Stocktalk | Seeking Alpha Read the latest StockTalks, investment ideas, and community discussion on Aurinia Pharmaceuticals Inc. (AUPH).